WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinshenker, D.
Right arrow Articles by Thomas, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinshenker, D.
Right arrow Articles by Thomas, J. H.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 15, 1999, 19(22):9831-9840

Block of an ether-a-go-go-Like K+ Channel by Imipramine Rescues egl-2 Excitation Defects in Caenorhabditis elegans

David Weinshenker1, 2, Aguan Wei3, Lawrence Salkoff3, 4, and James H. Thomas1

1 Department of Genetics, and 2 Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, Washington 98195, and 3 Departments of Anatomy and Neurobiology and 4 Genetics, Washington University School of Medicine, St. Louis, Missouri 63110


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

K+ channels are key regulators of cellular excitability. Mutations that activate K+ channels can lower cellular excitability, whereas those that inhibit K+ channels may increase excitability. We show that the Caenorhabditis elegans egl-2 gene encodes an eag K+ channel and that a gain-of-function mutation in egl-2 blocks excitation in neurons and muscles by causing the channel to open at inappropriately negative voltages. Tricyclic antidepressants reverse egl-2(gf) mutant phenotypes, suggesting that EGL-2 is a tricyclic target. We verified this by showing that EGL-2 currents are inhibited by imipramine. Similar inhibition is observed with the mouse homolog MEAG, suggesting that inhibition of EAG-like channels may mediate some clinical side effects of this class of antidepressants.

Key words: eag; K+ channel; tricyclic; antidepressant; imipramine; Caenorhabditis elegans; egl-2


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

K+ channels are key regulators of membrane excitability and are responsible for a number of identified channelopathies underlying neurological and cardiac disorders (Adelman et al., 1995; Curran et al., 1995; Vetter et al., 1996; Wang et al., 1996). In addition, some clinically used drugs may act via K+ channel blockade (Sanguinetti and Jurkiewicz, 1990). Caenorhabditis elegans contains a full complement of K+ channel gene families (Wei et al., 1996), and a number of K+ channel mutants have been identified (Elkes et al., 1997; Johnstone et al., 1997; our unpublished data). Behavioral and pharmacological studies of these mutants may provide insight into the genetic and mechanistic basis of K+ channel dysfunction in vivo.

Here we report that the behavioral defects in the C. elegans egl-2 mutant are caused by a gain-of-function (gf) mutation in an eag-like K+ channel. eag K+ channels are encoded by one of three distinct subfamilies of genes (eag, erg, and elk), which comprise the ether-a-go-go (EAG) extended gene family (Warmke and Ganetzky, 1994; Ganetzky et al., 1999). Members of the EAG family of K+ channels generally produce noninactivating, voltage-dependent potassium currents, characterized by accentuated modulation by internal (Bruggemann et al., 1993; Stansfeld et al., 1996) and external (Terlau et al., 1996; Schonherr et al., 1999) divalent cations. Amino acid residues critical for controlling channel activity are largely undefined, and in vivo mutant phenotypes have previously been described only for Drosophila (Kaplan and Trout, 1969; Warmke et al., 1991).

Imipramine and other structurally related tricyclic antidepressants reverse egl-2(gf) mutant phenotypes, but not those caused by gf mutations in other C. elegans potassium channel genes (Trent et al., 1983; Reiner et al., 1995; Weinshenker et al., 1995; our unpublished data), suggesting a specific interaction between tricyclics and EGL-2 channels. Tricyclic drugs are used to treat depression and other affective disorders, however their potential use is limited by many clinical side effects such as cardiac arrhythmia, weight fluctuation, constipation, and sexual dysfunction (Baldessarini, 1989; Kaplan et al., 1994). Tricyclics are thought to exert their therapeutic effect through chronic blockade of presynaptic serotonin and/or norepinephrine transporters (Frazer, 1997), but the molecular mechanisms mediating many of the deleterious side effects have not been identified. Previous studies have reported that some native K+ currents can be blocked by tricyclics (Wooltorton and Mathie, 1993; Valenzuela et al., 1994; Kuo, 1998), but the molecular identities of these channels are unknown.

To investigate the mechanism of the egl-2(gf) phenotype and rescue by imipramine, we analyzed EGL-2 currents in Xenopus oocytes. Mutant EGL-2(gf) channels exhibited a negative shift in voltage dependence of activation, and both wild-type (WT) and mutant currents were blocked by imipramine. We hypothesize that EGL-2(gf) channels cause behavioral defects through suppression of excitability in critical cells. Consistent with this possibility, EGL-2:: green fluorescent protein (GFP) fusions revealed egl-2 expression in a subset of neurons and muscles that could explain the mutant behavioral defects. Suppression of egl-2(gf) phenotypes by imipramine likely results from the block of EGL-2(gf) channels. We suggest that a similar block of vertebrate EAG-like potassium channels may mediate some of the clinical side effects of tricyclic antidepressants.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Behavioral assays. Chemotaxis assays were performed as described, with slight modifications (Bargmann et al., 1993). Eighteen- to 22-hr-old chemotaxis plates were allowed to dry coverless for 60 min before the assay, and 1 µl of 200 mM sodium azide was placed at the attractant and control spots to anesthetize the animals when they reached these spots. A minimum of three trials (at least 50 animals each) were performed for each genotype and attractant concentration. For the imipramine experiments, animals were grown on plates containing 0.7 ml of 2.4 mM imipramine (Sigma, St. Louis, MO) and assayed on chemotaxis plates (Bargmann et al., 1993) containing 315 µM imipramine. Statistical analysis was done using the unpaired Student's t test (Instat 2.01 for Macintosh).

Defecation assays were performed as described (Weinshenker et al., 1995). For each genotype, a minimum of 40 defecation cycles from at least three animals were assayed. Drug experiments were performed on plates containing 0.7 ml of 2.4 mM imipramine.

Anterior Mec assays were performed essentially as described (Chalfie and Sulston, 1981). Adult animals were picked individually to plates and assayed 45 min later. Each animal was tested for responsiveness to a light touch just posterior to the pharynx with an eyelash five times. For each genotype, at least 10 animals were touched five times each (one touch every 10 min). Imipramine experiments were performed on plates containing 0.7 ml of 2.4 mM imipramine.

Mutagenesis and mapping of egl-2(gf) revertants. Revertants of egl-2(gf) were isolated by mutagenizing egl-2(n693sd) and egl-2(n2656sd) with ethylmethanesulfonate (EMS) as described (Brenner, 1974) and screening for non-egg laying-defective (Egl) non-expulsion-defective (Exp) animals in the F2 generation. Transposon alleles of egl-2(n693sd) were similarly isolated by screening for revertants of egl-2(n693sd) in a mut-6 mutator background. We isolated 30 EMS-induced alleles from 110,000 mutagenized genomes and three transposon insertion alleles from 90,000 mutagenized genomes. Four EMS-induced revertants of egl-2(n693sd), n904, n905, n906, and n907, were kindly provided by C. Trent and H. R. Horvitz.

lon-2(e678) males were mated to revertant hermaphrodites, and F1 progeny were picked individually to plates and allowed to self-fertilize. F1 cross progeny were non-Egl non-Exp, indicating that the revertant alleles are cis-dominant. Broods containing lon-2 mutants were screened for egl-2(gf) animals to assess linkage between egl-2 and the suppressor. Approximately 1000 F2 progeny were screened for each revertant, and no egl-2(gf) animals were seen, indicating that all of the suppressors are tightly linked to egl-2.

egl-2 cloning. egl-2(n693sd) was mapped between unc-34 and unc-60 on the left arm of chromosome V (Trent et al., 1983; data not shown). Cosmids from the region (5 ng/µl) were coinjected with rol-6(d) marker DNA (200 ng/µl) into egl-2(n905) animals, and transgenic lines were established as described (Mello et al., 1991). egl-2(n693sd)/egl-2(n905) heterozygotes carrying the cosmid transgene were constructed, and partial suppression of the egl-2(n693sd) expulsion-defective (Exp) phenotype was obtained with cosmids ZK1005 and ZK1012. Overlapping regions from these cosmids were used to probe Southern blots of DNA from multiple egl-2 alleles, and polymorphisms were identified in a 1.6 kb XbaI fragment in the egl-2 alleles sa373, sa400, and sa408. This fragment was subcloned and sequenced, and the sequence was used to design primers for RT-PCR. Stratagene (La Jolla, CA) 5' and 3' rapid amplification of cDNA ends kits were used to obtain overlapping partial cDNAs, which were sequenced. egl-2 genomic sequence was subsequently confirmed by the C. elegans Genome Sequencing Consortium (Coulson, 1996). Oligonucleotides for PCR and sequencing were from Life Technologies (Gaithersburg, MD). PCR was performed on a PTC-200 DNA engine from MJ Research. Sequencing was performed on an ABI PRISM dye terminator cycle sequencer by the Biochemistry Sequencing facility and the Pharmacology Sequencing facility at the University of Washington. For mutant egl-2 alleles, PCR products from the egl-2 gene using mutant and wild-type genomic DNA as template were gel-purified and sequenced. The egl-2 cDNA GenBank accession number is AF130443.

Xenopus oocyte expression and electrophysiology. Three overlapping partial cDNAs were constructed by RT-PCR and cloned together into the pMXT oocyte expression vector (Wei et al., 1994). A silent mutation was introduced at base 2412 to create a SpeI site used in cloning. A full-length mouse ether-a-go-go (meag) clone (kindly provided by Barry Ganetzky) was cloned into the pMXT oocyte expression vector. The A478V mutation was introduced into the egl-2 cDNA by overlap PCR mutagenesis (Horton et al., 1989). The cDNA was cloned into pMXT and sequenced to confirm the change and rule out extraneous mutations. The A492V mutation in meag was similarly generated.

Capped cRNAs were generated by in vitro transcription using a commercial T3 RNA polymerase kit (mMessagemMachine; Ambion, Austin, TX) and linearized plasmid DNA templates. Oocyte isolation, injection, and handling followed standard procedures (Soreq and Seidman, 1992; Wei et al., 1994). Oocytes were injected with ~50 ng (wild-type and mutant egl-2) or 10 ng (wild-type and mutant meag) cRNA. Wild-type and mutant EGL-2 currents were obtained in choline 96 (in mM: 96 choline Cl, 2 KCl, 1.8 CaCl2, 1.0 MgCl2, and 5 HEPES, pH 7.5) supplemented with 1.0 mM 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid (Sigma) to block endogenous calcium-activated chloride currents (Barish, 1983) after 5-7 d of incubation at 19°C. Wild-type and mutant meag currents were obtained in ND96 (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 1.0 MgCl2, and 5 HEPES, pH 7.5) after 1-3 d incubation at 19°C. Current recordings were digitally acquired by two-electrode voltage clamp with a Dagan TEV-200 amplifier and pClamp 7 (Axon Instruments, Foster City, CA). Current injection and voltage electrodes had resistances between 0.5 and 1.0 MOmega filled with 3 M KCl. Imipramine (Sigma) solutions were made in either choline 96 (wild-type and mutant EGL-2) or ND96 (wild-type and mutant MEAG) and exchanged with the bath solution by gravity flow. Data analysis was performed with Sigmaplot 4.0 (Jandel Scientific, Corte Madera, CA) and Origin 4.0 (Microcal).

GFP expression. For the short fusion, a PCR product containing 4.1 kb of upstream sequence, the first exon and intron, and part of the second intron of egl-2 was inserted in frame into the pPD95.75 GFP expression vector (kindly provided by A. Fire, J. Ahnn, G. Seydoux, and S. Xu). For the full-length fusion, an NheI fragment from cosmid ZK1005 containing 5 kb upstream of egl-2, the entire egl-2 coding region (10 kb), and 4.2 kb downstream of egl-2 was cloned into the XbaI site of Bluescript (Stratagene). The GFP coding region was generated by PCR from pPD95.75 and cloned in frame into the AgeI site in exon 13 of egl-2 in the plasmid described above. The stop codon in GFP was mutated to a leucine codon so that the egl-2 gene would be translated in its entirety. The short fusion (200 ng/µl) was coinjected with lin-15(+) DNA (60 ng/µl) into lin-15(n765ts) mutants, which have the multivulva (Muv) phenotype. Non-Muv transgenic lines were established, GFP was visualized, and cell identities were determined using epifluorescence microscopy and Nomarski optics. The long fusion (100 ng/µl) was linearized with SphI and coinjected with rol-6(d) DNA (100 ng/µl) into wild-type animals. Rol transgenic lines were established, and serial images of L2 larvae were taken every 0.4 µm with a deconvoluting microscope using epifluorescence. Figure 5e is a compressed image of the sum of 38 sections.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

An egl-2 gain-of-function mutation causes multiple behavioral phenotypes

Two independently isolated dominant gain-of-function (gf) mutations in the C. elegans egl-2 gene (n693 and n2656) inhibit egg-laying and enteric muscle contraction, leading to Egl and Exp phenotypes. These mutant phenotypes are rapidly rescued by exposure to tricyclic antidepressants such as imipramine, suggesting that the egl -2 gene product is a tricyclic target. Pharmacological and cell ablation manipulations combined with behavioral assays suggest that the Egl and Exp defects are likely in the egg-laying and enteric muscles and not in the motor neurons that innervate them (Reiner et al., 1995; Weinshenker et al., 1995).

We tested egl-2 mutants for chemotaxis to volatile odorants, a behavior that is mediated by amphid sensory neurons. egl-2(gf) mutants were defective in chemotaxis to both isoamyl alcohol and benzaldehyde, which are sensed by the AWC amphid neuron (Bargmann et al., 1993). Similar to the muscle defects, the isoamyl alcohol defect was rescued by imipramine (Fig. 1). Although egl-2(gf) has a weak locomotory defect, they were outperformed in this assay by the more severely locomotion-defective unc-25 mutant (Fig. 1), suggesting that the egl-2(gf) chemotaxis defect is caused by sensory and not motor defects.



View larger version (38K):
[in this window]
[in a new window]
  		Figure 1.   Volatile chemotaxis response of egl-2 mutants to isoamyl alcohol. Chemotaxis indexes (CI) were calculated in the following way: CI = (number at attractant - number at control)/(total number) (Bargmann et al., 1993). Error bars indicate SD among individual trials. The egl-2(gf) allele was egl-2(n693sd), the egl-2(lf) allele was egl-2(n693sd sa236), and the unc-25 allele was unc-25(e156). Considering p < 0.05 as significant, egl-2(lf) is not significantly different from wild type at any dilution, egl-2(gf) is significantly different from wild type at every dilution, unc-25(e156) is significantly different from egl-2(gf) at all isoamyl alcohol dilutions except 10-4, and egl-2(gf) + imipramine is significantly different from egl-2(gf).

egl-2(gf) mutants also had an imipramine-sensitive anterior mechanosensory-defective (Mec) phenotype, which is mediated by the ALM mechanosensory neurons (Chalfie and Sulston, 1981) (Table 1). Previously characterized male mating and locomotion defects in egl-2(gf) mutant are likely neuronally mediated, and these are also rescued by imipramine (Trent et al., 1983; Weinshenker et al., 1995; data not shown). These results demonstrate that an egl-2(gf) mutation can compromise neuronal and muscle function, and that its interaction with tricyclics is similar in the two tissues.


                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Anterior Mec response of egl-2 mutants

egl-2(gf) revertants define three classes of eag mutations

To determine the loss-of-function (lf) phenotype for egl-2, we mutagenized egl-2(gf) animals and isolated revertants that were no longer Egl or Exp. All revertants were tightly linked to egl-2 (Materials and Methods), suggesting that they contain second site suppressors within the egl-2 gene.

To investigate the genetic properties of the revertants, we used the semidominance of the egl-2(gf) alleles in gene dosage tests. The enteric muscle contraction (EMC) defect of egl-2(gf) in trans to a deficiency of egl-2 is more severe than the gf in trans to a wild-type copy of egl-2 (Table 2). A null mutation of egl-2 in trans to the gf would be expected to behave like a deficiency, whereas non-null mutations might give different results. We put each revertant in trans to egl-2(gf) and measured EMC defects (Table 2). The revertants fell into three classes. Class I alleles (20 alleles), such as sa236, behaved like an egl-2 deficiency and probably are strong lf or null mutations. As homozygotes, egl-2(sa236) and other members of this class of revertants appear wild-type, having no gross defects in movement, feeding, fertility, defecation, egg laying, or chemotaxis to volatile odorants (Tables 1, 2, Fig. 1; data not shown). Class II alleles (four alleles) behaved like a wild-type copy of egl-2. Class III alleles (eight alleles) suppressed the gf to a greater degree than a wild-type allele, and thus are probably dominant-negative alleles.


                              
View this table:
[in this window]
[in a new window]
  		Table 2.   Analysis of enteric muscle contraction in egl-2 mutants

egl-2 encodes a voltage-gated K+ channel

To determine the role of egl-2 in cell excitation and the nature of the tricyclic antidepressant interaction, we cloned egl-2 (Materials and Methods). egl-2 encodes an eag-like voltage-gated K+ channel (VGK) (Fig. 2a) (GenBank accession number AF130443). The EGL-2 and Drosophila eag proteins are 54% identical in the N terminus, 75% identical in the transmembrane and pore domain, and 81% identical in the domain with homology to cyclic nucleotide-binding proteins (cNTP), but are divergent at the C terminus. The molecular lesion in the two independently isolated egl-2(gf) alleles is an A478V change in the S6 domain. This alanine is conserved among nearly all VGKs described to date, suggesting that this residue is critical for normal channel function (Fig. 2b). The Class I sa236 mutation results in a stop codon at amino acid 84 (Fig. 2a), and thus is probably a null allele. We identified molecular lesions for four Class III dominant negative alleles. These lesions all cause single missense mutations affecting residues near S1 and S2: S213F (sa395), T230M (sa377), and T285I (sa378 and sa391) (Fig. 2a).



View larger version (89K):
[in this window]
[in a new window]
  		Figure 2.   Alignment of EGL-2 with other K+ channels. a, Predicted amino acid sequence of the egl-2 gene product and the molecular lesions found in mutant alleles aligned with Drosophila eag (EAG) and mouse eag (MEAG). The predicted transmembrane and pore domains are underlined, as is the region with homology to cyclic nucleotide-binding proteins (cNTP BINDING DOMAIN). Amino acid identities are boxed in black. Amino acids changed in mutant egl-2 alleles are outlined in black and annotated on the line above. GFP fusion junctions are shown by vertical gray lines. b, Alignment of the sixth transmembrane domain (S6) of EGL-2 and other K+ channels. dEAG and dSHAKER are Drosophila channels, UNC-103 is a C. elegans erg homolog, HERG (human erg; mutated in long QT syndrome), KVLQT1 (mutated in long QT syndrome), and hSK1 (small conductance Ca2+-activated K+ channel) are human channels, mSLO is a mouse large conductance Ca2+-activated K+ channel, and AKT1 is an Arabidopsis inward-rectifying K+ channel. The alanine that is mutated in egl-2(gf) alleles and the corresponding residues in other channels are boxed. GenBank accession numbers for sequences used: EGL-2 (AF130443), MEAG (UO4294), Drosophila EAG (M61157), Drosophila Shaker (M17211), UNC-103 (Z35596), HERG (UO4270), KVLQT1 (U89364), hSK1 (AF131938), mSLO (L16912), and AKT1 (X62907).

S6 mutation shifts voltage dependence of activation for EGL-2 and murine MEAG channels

To investigate the mechanism underlying the in vivo phenotype of the egl-2(gf) mutations, we studied the properties of WT and gf mutant (A478V) EGL-2 channels expressed in Xenopus oocytes. Oocytes injected with wild-type egl-2 cRNA expressed voltage-dependent, noninactivating potassium currents characterized by unusually slow activation kinetics, requiring voltage steps of 5 sec to approach steady-state (Fig. 3a). A conductance-voltage (G-V) plot of WT EGL-2 currents revealed a voltage of half-maximal activation (V50) of -7 mV, centered within a voltage-operating range of ~80 mV (Fig. 3b). Oocytes injected with mutant egl-2(A478V) cRNA expressed similar nonactivating potassium currents, but with altered voltage dependence of activation (Fig. 3a). G-V plots for A478V EGL-2 channels revealed a V50 of -40 mV, a shift of -33 mV relative to WT EGL-2 channels (Fig. 3b). This hyperpolarized shift in the V50 of A478V EGL-2 channels allows a significant fraction of available mutant channels to be activated at hyperpolarized potentials. This is consistent with the observed mutant behavioral phenotypes of egl-2(gf) mutants, because a muscle or neuron expressing these mutant channels may be hyperpolarized and unable to respond appropriately to excitatory stimuli.



View larger version (37K):
[in this window]
[in a new window]
  		Figure 3.   Functional properties of wild-type and gain-of-function EGL-2 and MEAG K+ channels in Xenopus oocytes assayed by two-electrode voltage-clamp. a, Current records from oocytes injected with wild-type egl-2, gain-of-function egl-2(A478V), and corresponding meag and meag(A492V) cRNAs. Currents evoked by families of voltage steps from a holding potential of -100 mV, in 10 mV increments [-90 to +40 mV for egl-2 and egl-2(A478V)); -90 to +50 mV for MEAG and MEAG(A492V)]. Outward tail currents observed from wild-type EGL-2 channels resulted from a repolarization step to -50 mV. A -100 mV repolarization step was used for all other channels. b, Normalized conductance-voltage relationships. Conductances were calculated from current amplitudes at the end of 5 sec [EGL-2 and EGL-2(A478V)] and 2 sec [MEAG and MEAG(A492V)] voltage steps, based on a reversal potential of -90 mV in ND96. Individual data sets were fitted by a single Boltzmann function, G/Gmax = (1 + exp(-n(V - V50)/kT))-1, where n is the slope factor reflecting intrinsic voltage sensitivity, V50 is the voltage at half-maximal conductance, and T is absolute temperature. Mean values were plotted with SEM.

A478 is positioned near residues thought to undergo gating-dependent conformational changes in the Shaker potassium channel (Liu et al., 1997; Holmgren et al., 1998). We therefore tested the ability of the A478V substitution to confer a gf phenotype in the murine eag homolog meag (Warmke and Ganetzky, 1994), by engineering an analogous missense mutation in MEAG (A492V). A492V MEAG channels exhibited a G-V shifted toward hyperpolarized potentials (V50 = -13.7 mV) relative to WT MEAG (V50 = -3.4 mV) (Fig. 3a,b), demonstrating a modest, but functionally similar effect of this substitution in a mouse eag-like channel

Imipramine blocks EGL-2 and MEAG channels

To determine the mechanism of imipramine rescue of the egl-2(gf) phenotypes, we assessed its ability to block EGL-2 channels in oocytes. Imipramine was able to block both WT and A478V EGL-2 channels (Fig. 4). The derived Hill coefficients (s = 0.84, WT; s = 0.80, A478V) suggest a binding stoichiometry of one imipramine molecule to one channel. Similar results were obtained with WT MEAG channels (Fig. 4), except that imipramine inhibits WT MEAG currents with an ~10-fold lower potency (Kd = 55 µM) than EGL-2 currents.



View larger version (34K):
[in this window]
[in a new window]
  		Figure 4.   Imipramine inhibits EGL-2 and MEAG channels. Dose-response plots for wild-type EGL-2, EGL-2(A478V), and MEAG currents, measured at 40 mV, at the end of 5 sec [EGL-2 and EGL-2(A478V)] and 2 sec (MEAG) voltage steps from a holding potential of -100 mV. Individual data sets normalized to maximal current evoked in ND96 and fitted by the Hill function, I = 1 -(max/(1 + (Kd/[imipramine])s)), where max is the maximal fractional inhibition, Kd is the imipramine concentration at half-maximal inhibition, and s is the slope factor. Mean values were plotted with SEM.

Block by imipramine at each test concentration was rapid and essentially complete within the ~2 min allowed for equilibration between exchanges of bath solutions, at the holding potential of -100 mV. A variable secondary component of block was observed with much slower kinetics, perhaps reflecting state dependence of block (Kuo, 1998). This secondary component of block may account for the residual 10% of channels not blocked with our assay conditions (Fig. 4). Block was not observed to be reversible by washes of up to 30 min, consistent with a slow off-rate of imipramine. The rapid and dose-dependent inhibition of EGL-2 and MEAG channels provides evidence that imipramine directly blocks these channels and suggests that imipramine may block other EAG-like channels with similar efficacy.

EGL-2:: GFP fusions are expressed in muscle and neurons

To determine the cellular expression pattern of egl-2, we constructed two EGL-2:: GFP fusions (Materials and Methods; Fig. 2a). Consistent with the Exp defect of egl-2(gf) mutants, the short fusion (4.1 kb of upstream egl-2 sequence) was expressed in the intestinal muscles, which are two of the four enteric muscles (Fig. 5a). We hypothesize that inappropriately activated EGL-2 K+ channels in these muscles compromise their ability to depolarize and contract. In addition to the muscle expression, the short fusion was expressed in the AFD, ALN, AQR, ASE, AWC, BAG, IL2, PLN, PQR, and URX neurons in hermaphrodites and males, and in a subset of ray sensory neurons in males (Fig. 5b; data not shown). The expression in AWC is consistent with the chemotaxis defect in egl-2(gf) mutants (Fig. 1). Because ray neurons are involved in mating (Liu and Sternberg, 1995), egl-2 expression in rays may underlie the previously characterized male mating defect of egl-2(gf) mutants (Trent et al., 1983).



View larger version (105K):
[in this window]
[in a new window]
  		Figure 5.   egl-2 expression. Anterior is left, dorsal is up. Merged Nomarski and GFP fluorescence images. a, Short EGL-2:: GFP expression in the intestinal muscles (posterior end of an adult animal). GFP-expressing cells posterior to the intestinal muscle are the tail neurons ALN and PLN in a slightly lower focal plane. b, Short EGL-2:: GFP expression in neurons in the lateral ganglion (anterior end of the animal). Posterior to the IL2 neurons, BAGL and AWCL are also visible, but faint. Other GFP-expressing cells in this region are either faint or out of focus. c, Long EGL-2:: GFP expression in the ALM mechanosensory neurons. d, Long EGL-2:: GFP expression in the vulval muscles used for egg laying. e, Deconvoluted image of full-length EGL-2:: GFP fusion expression in sensory neuron endings.

The long fusion (5 kb of upstream egl-2 sequence, the entire 10 kb egl-2 coding region, and 4.2 kb of downstream egl-2 sequence) was highly localized at dendritic endings of neurons in the nose, but only faintly in the processes (Fig. 5e). This localization is probably in the ciliated endings of head sensory neurons. Neuronal cell bodies in the lateral ganglion also label with this fusion (Fig. 5e). This fusion was also expressed in the ALM mechanosensory neurons (Fig. 5c), which can explain the egl-2(gf) anterior Mec phenotype (Table 1). Consistent with the Egl defect of egl-2(gf) mutants, we saw occasional expression of this fusion in the vulval muscles used for egg laying (Fig. 5d).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

egl-2 encodes a voltage-gated K+ channel that is blocked by the tricyclic antidepressant imipramine. The egl-2(gf) mutation produces a negative shift in the voltage dependence of activation of EGL-2 channels, thus increasing the likelihood of open channels at hyperpolarized potentials. We propose that the egl-2(gf) phenotypes result from an inappropriate suppression of excitability in cells that express the mutant channel. Imipramine blocks the mutant channel and restores function by inhibiting the suppression of excitability. This model is supported by the close parallel between behavioral defects in egl-2(gf) mutants and EGL-2:: GFP expression in cells that mediate these behaviors (Fig. 6).



View larger version (31K):
[in this window]
[in a new window]
  		Figure 6.   Summary of egl-2(gf) phenotypes, EGL-2 expression, and rescue by imipramine. Mutant EGL-2 channels are expressed in muscle and neurons and cause excitation defects by allowing an inappropriate efflux of K+ in these cells. Imipramine rescues egl-2(gf) phenotypes by blocking the mutant channels and restoring excitability.

egl-2(lf) phenotypes

We did not detect any gross behavioral defects in egl-2(lf) mutants. We speculate that there are many K+ channels with overlapping functions in the excitable cells of C. elegans, and that loss of any one of them does not greatly affect cellular excitability. Conversely, activation of some of these channels causes an excitability phenotype out of proportion to their wild-type contribution. This generalization is supported by the severe phenotypes caused by gf mutations, in contrast to mild or absent phenotypes caused by lf mutations, in other C. elegans K+ channels (Reiner et al., 1995; Elkes et al., 1997; Johnstone et al., 1997).

EGL-2 expression

The expression of the short EGL-2:: GFP fusion in two of the four enteric muscles is consistent with the enteric muscle contraction defect of egl-2(gf) mutants. Vulval muscle labeling was observed in occasional animals expressing the long fusion, which can explain the Egl defect in egl-2(gf) mutants. This is consistent with the pharmacology of the egl-2(gf) Egl phenotype, as agonists that act directly on the egg-laying muscles to promote egg laying in the wild type fail to do so in egl-2(gf) mutants (Trent et al., 1983; Weinshenker et al., 1995). Interestingly, nearly all neurons that express the fusions are sensory neurons, suggesting that egl-2 serves a common function in C. elegans sensory neurons of different modalities.

Like the long EGL-2:: GFP fusion, components of the odorant-sensing machinery are localized to the ciliated endings of amphid sensory neurons (Coburn and Bargmann, 1996; Sengupta et al., 1996; Colbert et al., 1997; Roayaie et al., 1998). It is possible that EGL-2 functions in sensory endings and is modulated by components of sensory transduction. Drosophila eag mutants are defective in odorant response (Dubin et al., 1998), and rat eag is expressed in the olfactory bulb (Ludwig et al., 1994), suggesting conservation of an eag function in olfaction. In addition, bovine eag is expressed in retinal photoreceptors and may encode the native IKx current, suggesting a general role for eag in sensory transduction processes (Frings et al., 1998).

K+ channel structure and function

Voltage-gated K+ channels display a remarkable heterogeneity of intrinsic properties, reflected in the molecular diversity of K+ channel genes (Wei et al., 1996). The fact that the EGL-2 S6 alanine 478 is highly conserved among all families of VGKs suggests that it is critical for some aspect of normal channel function. This is supported by the gf shifts in G-V conferred by a modest change to a valine in EGL-2 and MEAG. Changing the analogous alanine in KVLQT1 channels to valine or glutamate results in the cardiac arrhythmia long QT syndrome, a probable dominant-negative phenotype (Wang et al., 1996; Shalaby et al., 1997). These mutations focus attention on S6 as an important structure mediating channel function.

Examples of S6 amino acid substitution that either stabilize channel open states or accelerate transitions from closed to open states have been observed in a wide variety of other K+ channels. These include Shaw K+ channels (Elkes et al., 1997; Johnstone et al., 1997), Slo-type calcium-activated K+ channels (Lagrutta et al., 1994), the yeast YKC1 K+ channel (Loukin et al., 1997), and the Shaker K+ channel (Liu et al., 1997; Holmgren et al., 1998). Our data suggest that elements of the gating mechanism mediated by S6 may be conserved between K+ channels from diverse gene families. This suggestion is supported by the conserved "inverted teepee" structural motif revealed by the crystal structures of the Kcsa K+ channel from Streptomyces lividans (Doyle et al., 1998) and the MscL cation channel from Mycobacterium tuberculosis (Chang et al., 1998). In both structures, the ion conduction pathway is lined by a single tilted transmembrane alpha -helix contributed by each subunit. This critical alpha -helix is TM2 for Kcsa, TM1 for MscL and, by analogy, S6 for voltage-gated K+ channel subunits. Rotation and translational movements of TM1 and TM2 underlie pH-dependent gating of the Kcsa channel (Perozo et al., 1999) and may provide a conserved structural mechanism used for gating in other potassium channels. Mutations of critical S6 residues could affect gating properties by influence the energetics of these conformational changes. Our data with egl-2 and meag are consistent this possibility.

The egl-2(gf) revertants may provide information about K+ channel structure and function. The Class II revertants restore relatively normal function to the gf mutant channels. These are probably second site mutations that compensate for the gf mutation, and they potentially provide mechanistic information about channel gating. The Class III alleles behave as dominant negatives. These mutations may suppress the gf mutation by directly or allosterically countering the action of A478V in S6. Alternatively, the suppressors could inhibit proper channel folding or processing independent of A478V. These alleles may provide a useful in vivo model for studying dominant-negative K+ channel subunit interactions.

Imipramine block of eag channels

We show that EGL-2 and MEAG channels are rapidly blocked by externally applied imipramine in a saturable fashion, with a high affinity in the range of 10-100 µM. These properties are in agreement with previous studies describing imipramine block of native K+ channels from cardiac myocytes (Isenberg and Tamargo, 1985), peripheral sensory neurons (Ogata and Tatebayashi, 1993; Wooltorton and Mathie, 1993, 1995), and hippocampal neurons (Kuo, 1998). Both noninactivating and transient native potassium currents are blocked by imipramine, depending on the tissue source. All reported native imipramine-sensitive currents tested have binding constants in the range of 10-100 µM and a putative external binding site. Our results suggest that these imipramine-sensitive currents may be encoded by K+ channel genes of the EAG gene family. Consistent with this possibility, heterologous expression studies reveal that the EAG gene family is capable of producing homomeric K+ channels with a diversity of kinetic properties, encompassing both noninactivating (eag, erg, elk subfamilies) and transient (erg, elk subfamilies) channel types (Shi et al., 1997, 1998; Engeland et al., 1998). Among gf mutations in C. elegans that have been shown or hypothesized to activate K+ channels, egl-2(gf) is the only one that is rescued by imipramine (Reiner et al., 1995; Elkes et al., 1997; Johnstone et al., 1997), suggesting a specific tricyclic-EAG interaction. The higher concentrations of imipramine required to rescue egl-2(gf) behavioral defects in vivo (~25 µM; E. Round, personal communication) than to block EGL-2 in vitro (~10 µM) is likely due to the general impermeability of the C. elegans cuticle (Lewis et al., 1980). Should imipramine show specificity for K+ channels encoded by the EAG gene family, it may provide an attractive molecular substrate for the rational design of blocking agents that target members of this family (Mathie et al., 1998).

EAG channels, tricyclic antidepressants, and human disease

The interaction between tricyclic antidepressants and EGL-2 provides a link that may explain one of the most common side effects of these psychotropic drugs. Long QT syndrome is a cardiac arrhythmia that can either be inherited or caused by drugs that block K+ channels (Tan et al., 1995). One inherited form is associated with dominant-negative mutations in HERG, a VGK in the EAG gene family that encodes the cardiac IKr K+ current (Sanguinetti et al., 1995; Trudeau et al., 1995). Tricyclics can cause long QT syndrome, and we speculate that they may do so in part by blocking HERG channels. In support of this model, imipramine can significantly block IKr currents in ventricular myocytes at concentrations found in the serum of patients taking clinical doses of the drug (~1 µM; Baldessarini, 1989; Valenzuela et al., 1994). In addition, a human eag channel (h-eag) has recently been cloned, and both h-eag and rat eag channels are expressed in brain (Ludwig et al., 1994; Occhiodoro et al., 1998). h-eag and meag are 100% conserved in the transmembrane and pore regions, indicating that imipramine probably blocks h-eag channels. Our results suggest that acute cardiac and neurological side effects of imipramine use may result from the block of HERG, h-eag, or other K+ channels encoded by the EAG gene family.

Putative targets of psychotropic drugs have been determined traditionally by assaying binding to known receptors in vitro. The combination of genetics and pharmacology in C. elegans offers an alternative means to identify and study these targets in vivo.


    FOOTNOTES

Received July 6, 1999; revised Sept. 13, 1999; accepted Sept. 22, 1999.

This work was supported by Public Health Service Grants R01NS30187 (J.T.) and RO1NS24785 (L.S.). Many nematode strains were provided by the Caenorhabditis Genetics Center. We thank Andy Fire for green fluorescent protein vectors, Bob Horvitz for strains, Cori Bargmann for chemotaxis advice, Marty Chalfie for Mec advice, Stan Fields for use of his deconvoluting microscope, Elaine Round for sharing unpublished data, and Michael Nonet for comments on this manuscript. The following people contributed valuable technical assistance and intellect: Dave Reiner, Betsy Malone, Liz Newton, Duncan Johnstone, Kouichi Iwasaki, Helen Chamberlin, Peter Swoboda, Mark Hamblin, Robert Choy, and Hong Tian. We thank L. Devarayalu at the University of Washington Biochemistry Sequencing Facility.

D.W. and A.W. contributed equally to this work

Correspondence should be addressed to James H. Thomas, Box 357360, Department of Genetics, University of Washington, Seattle, WA 98195. E-mail: jht{at}genetics.washington.edu.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Adelman JP, Bond CT, Pessia M, Maylie J (1995) Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15:1449-1454[ISI][Medline].
  • Baldessarini RJ (1989) Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 50:117-126[ISI][Medline].
  • Bargmann CI, Hartwieg E, Horvitz HR (1993) Odorant-selective genes and neurons mediate olfaction in C. elegans. Cell 74:515-527[ISI][Medline].
  • Barish ME (1983) A transient calcium-dependent chloride current in the immature Xenopus oocyte. J Physiol (Lond) 342:309-325[Abstract/Free Full Text].
  • Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71-94[Abstract/Free Full Text].
  • Bruggemann A, Pardo LA, Stuhmer W, Pongs O (1993) Ether-a-go-go encodes a voltage-gated channel permeable to K+ and Ca2+ and modulated by cAMP. Nature 365:445-448[Medline].
  • Chalfie M, Sulston J (1981) Developmental genetics of the mechanosensory neurons of Caenorhabditis elegans. Dev Biol 82:358-370[ISI][Medline].
  • Chang G, Spencer RH, Lee AT, Barclay MT, Rees DC (1998) Structure of the MscL homolog from Mycobacterium tuberculosis: A gated mechanosensitive ion channel. Science 282:2220-2226[Abstract/Free Full Text].
  • Coburn CM, Bargmann CI (1996) A putative cyclic nucleotide-gated channel is required for sensory development and function in C. elegans. Neuron 17:695-706[ISI][Medline].
  • Colbert HA, Smith TL, Bargmann CI (1997) OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans. J Neurosci 17:8259-8269[Abstract/Free Full Text].
  • Coulson A (1996) The Caenorhabditis elegans genome project. C. elegans genome consortium. Biochem Soc Trans 24:289-291[ISI][Medline].
  • Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80:795-803[ISI][Medline].
  • Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, MacKinnon R (1998) The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 280:69-77[Abstract/Free Full Text].
  • Dubin AE, Liles MM, Harris GL (1998) The K+ channel gene ether a go-go is required for the transduction of a subset of odorants in adult Drosophila melanogaster. J Neurosci 18:5603-5613[Abstract/Free Full Text].
  • Elkes DA, Cardozo DL, Madison J, Kaplan JM (1997) EGL-36 Shaw channels regulate C. elegans egg-laying muscle activity. Neuron 19:165-174[ISI][Medline].
  • Engeland B, Neu A, Ludwig J, Roeper J, Pongs O (1998) Cloning and functional expression of rat ether-a-go-go-like K+ channel genes. J Physiol (Lond) 513:647-654[Abstract/Free Full Text].
  • Frazer A (1997) Pharmacology of antidepressants. J Clin Psychopharmacol 17:2S-18S.
  • Frings SJ, Brull N, Dzeja C, Angele A, Hagen V, Kaupp UB, Baumann A (1998) Characterization of ether-a-go-go channels present in photoreceptors reveals similarity to IKx, a K+ current in rod inner segments. J Gen Physiol 111:583-599[Abstract/Free Full Text].
  • Ganetzky B, Robertson GA, Wilson GF, Trudeau MC, Titus SA (1999) The eag family of K+ channels in Drosophila and mammals. Ann NY Acad Sci 868:356-369[Abstract/Free Full Text].
  • Holmgren M, Shin KS, Yellen G (1998) The activation gate of a voltage-gated K+ channel can be trapped in the open state by an intersubunit metal bridge. Neuron 21:617-621[ISI][Medline].
  • Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68[ISI][Medline].
  • Isenberg G, Tamargo J (1985) Effect of imipramine on calcium and potassium currents in isolated bovine ventricular myocytes. Eur J Pharmacol 108:121-131[ISI][Medline].
  • Johnstone DB, Wei A, Butler A, Salkoff L, Thomas JH (1997) Behavioral defects in C. elegans egl-36 mutants result from potassium channels shifted in voltage-dependence of activation. Neuron 19:151-164[ISI][Medline].
  • Kaplan WD, Trout WE (1969) The behavior of four neurological mutants of Drosophila. Genetics 61:399-409[Free Full Text].
  • Kaplan HI, Sadock BJ, Grebb JA (1994) Major depressive disorder and bipolar I disorder. In: Synopsis of psychiatry (Retford DC, ed), pp 516-555. Baltimore: Williams and Wilkins.
  • Kuo CC (1998) Imipramine inhibition of transient K+ current: an external open channel blocker preventing fast inactivation. Biophys J 12:2845-2857.
  • Lagrutta A, Shen KZ, North RA, Adelman JP (1994) Functional differences among alternatively spliced variants of Slowpoke, a Drosophila calcium-activated potassium channel. J Biol Chem 269:20347-20351[Abstract/Free Full Text].
  • Lewis JA, Wu C-H, Berg H, Levine JH (1980) The genetics of levamisole resistance in the nematode Caenorhabditis elegans. Genetics 95:905-928[Abstract/Free Full Text].
  • Liu KS, Sternberg PW (1995) Sensory regulation of male mating behavior in Caenorhabditis elegans. Neuron 14:79-89[ISI][Medline].
  • Liu Y, Holmgren M, Jurman ME, Yellen G (1997) Gated access to the pore of a voltage-dependent K+ channel. Neuron 19:175-84[ISI][Medline].
  • Loukin SH, Vaillant B, Zhou XL, Spalding EP, Kung C, Saimi Y (1997) Random mutagenesis reveals a region important for gating of the yeast K+ channel Ykc1. EMBO J 16:4817-4825[ISI][Medline].
  • Ludwig J, Terlau H, Wunder F, Bruggemann A, Pardo LA, Marquardt A, Stuhmer W, Pongs O (1994) Functional expression of a rat homolog of the voltage gated ether a go-go potassium channel reveals differences in selectivity and activation kinetics between the Drosophila channel and its mammalian counterpart. EMBO J 13:4451-4458[ISI][Medline].
  • Mathie A, Wooltorton JR, Watkins CS (1998) Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol 30:13-24[ISI][Medline].
  • Mello CC, Kramer JM, Stinchcomb D, Ambros V (1991) Efficient gene transfer in C. elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10:3959-3970[ISI][Medline].
  • Occhiodoro T, Bernheim L, Liu J-H, Bijlenga P, Sinnreich M, Bader CR, Fischer-Lougheed J (1998) Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett 434:177-182[ISI][Medline].
  • Ogata N, Tatebayashi H (1993) Differential inhibition of a transient K+ current by chlorpromazine and 4-aminopyridine in neurons of the rat dorsal root ganglia. Br J Pharmacol 109:1239-1246[ISI][Medline].
  • Perozo E, Cortes DM, Cuello LG (1999) Structural rearrangements underlying K+-channel activation gating. Science 285:73-78[Abstract/Free Full Text].
  • Reiner DJ, Weinshenker D, Thomas JH (1995) Analysis of dominant mutations affecting muscle excitation in Caenorhabditis elegans. Genetics 141:961-976[Abstract].
  • Roayaie K, Crump JG, Sagasti A, Bargmann CI (1998) The G alpha protein ODR-3 mediates olfactory and nociceptive function and controls cilium morphogenesis in C. elegans olfactory neurons. Neuron 20:55-67[ISI][Medline].
  • Sanguinetti MC, Jurkiewicz NK (1990) Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 96:195-215[Abstract/Free Full Text].
  • Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81:299-307[ISI][Medline].
  • Schonherr R, Hehl S, Terlau H, Baumann A, Heinemann SH (1999) Individual subunits contribute independently to slow gating of bovine EAG potassium channels. J Biol Chem 274:5362-5369[Abstract/Free Full Text].
  • Sengupta P, Chou JH, Bargmann CI (1996) odr-10 encodes a seven transmembrane domain olfactory receptor required for responses to the odorant diacetyl. Cell 84:899-909[ISI][Medline].
  • Shalaby FY, Levesque PC, Yang WP, Little WA, Conder ML, Jenkins-West T, Blanar MA (1997) Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 96:1733-1736[Abstract/Free Full Text].
  • Shi W, Wymore RS, Wang HS, Pan Z, Cohen IS, McKinnon D, Dixon JE (1997) Identification of two nervous system-specific members of the erg potassium channel gene family. J Neurosci 17:9423-9432[Abstract/Free Full Text].
  • Shi W, Wang HS, Pan Z, Wymore RS, Cohen IS, McKinnon D, Dixon JE (1998) Cloning of a mammalian elk potassium channel gene and EAG mRNA distribution in rat sympathetic ganglia. J Physiol (Lond) 511:675-682[Abstract/Free Full Text].
  • Soreq H, Seidman S (1992) Xenopus oocyte microinjection: from gene to protein. Methods Enzymol 207:225-265[ISI][Medline].
  • Stansfeld CE, Roper J, Ludwig J, Weseloh RM, Marsh SJ, Brown DA, Pongs O (1996) Elevation of intracellular calcium by muscarinic receptor activation induces a block of voltage-activated rat ether-a-go-go channels in a stably transfected cell line. Proc Natl Acad Sci USA 93:9910-9914[Abstract/Free Full Text].
  • Tan HL, Hou CJ, Lauer MR, Sung RJ (1995) Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 122:701-714[Abstract/Free Full Text].
  • Terlau H, Ludwig J, Steffan R, Pongs O, Stuhmer W, Heinemann SH (1996) Extracellular Mg2+ regulates activation of rat eag potassium channel. Pfügers Arch 432:301-312[ISI][Medline].
  • Trent C, Tsung N, Horvitz HR (1983) Egg-laying defective mutants of the nematode C. elegans. Genetics 104:619-647[Abstract/Free Full Text].
  • Trudeau MC, Warmke JW, Ganetzky B, Robertson GA (1995) HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269:92-95[Abstract/Free Full Text].
  • Valenzuela C, Sanchez-Chapula J, Delpon E, Elizalde A, Perez O, Tamargo J (1994) Imipramine blocks rapidly activating and delays slowly activating K+ current activation in guinea pig ventricular myocytes. Circ Res 74:687-699[Abstract/Free Full Text].
  • Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, Marcus DC, Lazdunski M, Heinemann SF, Barhanin J (1996) Inner ear defects induced by null mutation of the isk gene. Neuron 17:1251-1264[ISI][Medline].
  • Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT (1996) Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12:17-23[ISI][Medline].
  • Warmke J, Drysdale R, Ganetzky B (1991) A distinct potassium channel polypeptide encoded by the Drosophila eag locus. Science 252:1560-1562[Abstract/Free Full Text].
  • Warmke JW, Ganetzky BA (1994) Family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 91:3438-3442[Abstract/Free Full Text].
  • Wei A, Solaro C, Lingle C, Salkoff L (1994) Calcium sensitivity of BK-type KCa channels determined by a separable domain. Neuron 13:671-681[ISI][Medline].
  • Wei A, Jegla T, Salkoff L (1996) Eight potassium channel families revealed by the C. elegans genome project. Neuropharmacology 35:805-829[ISI][Medline].
  • Weinshenker D, Garriga G, Thomas JH (1995) Genetic and phamacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci 15:6975-6985[Abstract/Free Full Text].
  • Wooltorton JRA, Mathie A (1993) Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds. Br J Pharmacol 110:1126-1132[ISI][Medline].
  • Wooltorton JR, Mathie A (1995) Potent block of potassium currents in rat isolated sympathetic neurones by the uncharged form of amitriptyline and related tricyclic compounds. Br J Pharmacol 116:2191-2200[ISI][Medline].

Copyright © 1999 Society for Neuroscience  0270-6474/99/19229831-10$05.00/0


This article has been cited by other articles:


Home page
 J. Neurophysiol.Home page
S. Faumont, T. Boulin, O. Hobert, and S. R. Lockery
Developmental Regulation of Whole Cell Capacitance and Membrane Current in Identified Interneurons in C. elegans
J Neurophysiol, June 1, 2006; 95(6): 3665 - 3673.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. Carvelli, P. W. McDonald, R. D. Blakely, and L. J. DeFelice
Dopamine transporters depolarize neurons by a channel mechanism
PNAS, November 9, 2004; 101(45): 16046 - 16051.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Physiol.Home page
R. E. Garcia-Ferreiro, D. Kerschensteiner, F. Major, F. Monje, W. Stuhmer, and L. A. Pardo
Mechanism of Block of hEag1 K+ Channels by Imipramine and Astemizole
J. Gen. Physiol., September 27, 2004; 124(4): 301 - 317.
[Abstract] [Full Text] [PDF]